Skip to content

Nerve Block In Frozen Shoulder

Functional Outcomes Of Triple Block Technique Vs Suprascapular Nerve Block In Frozen Shoulder : A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050349
Enrollment
40
Registered
2023-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Triple Nerve Block: Suprascapular nerve block + Lateral Pectoral nerve block + Axillary nerve block Drug solution for block consists of 0.25 % bupivacaine plus 80 mg methylprednisolone

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years Diagnostic criteria of frozen shoulder- Zuckerman’s criteria consist of: -Sudden onset. -Range of motion (ROM) during the active and passive elevation of the shoulders -ROM limitation in external rotation -Shoulder pain during the night. -Normal radiographical findings

Exclusion criteria

Exclusion criteria: Prior surgery on shoulder joint, prior intra-articular injections in shoulder joint, prior nerve blocks, prior scapula fracture, gleno-humeral arthritis, massive rotator cuff tear, cerebrovascular disease and cervical radiculopathy. Uncontrolled diabetes with (HBA1c more than 7.5). Patients who will refuse the intervention.

Design outcomes

Primary

MeasureTime frame
pre-intervention- Age, Sex, BMI, Limb side, Shoulder AP view, Blood investigations (ESR, CRP, FBS, HBA1c, RA factor, Thyroid profile), Duration of symptoms, Chief complaints during intervention- Procedure duration, Number of fluoroscopic shots post- intervention- VAS score, ASES Score, Korean Shoulder Score, Constant murley score, Oxford shoulder score, Shoulder pain and disability index (SPADI) Range of motion (Abd, forward flexion, IR, ER), Rebound pain Timepoint: The patient will be followed up after 30 minutes post-intervention, Post-intervention Day 1, Post-intervention Day 3, 2 Weeks, 4 Weeks, 6 Weeks, 12 Weeks.

Secondary

MeasureTime frame
NONETimepoint: NONE

Countries

India

Contacts

Public ContactYasim Khan

Hamdard Institute of Medical Sciences and Research and associated HAHC Hospital

yashimnp@gmail.com7838665515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026